Open original FDA record ↗Recall record
- FDA identifier
- Z-0912-2013
- Company in FDA record
- Atricure Inc
- FDA classification date
- Mar 6, 2013
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Products from lot no. 41865 may have been sent out with Incorrect Instructions for Use (IFU) labeling.
Source facts
- Action
- AtriCure sent a Urgent Medical Device Recall/Correction letter dated January 14, 2013, to all affected customers. The letter identified the product the problem and the action to be taken by the customer. AtriCure has identified that products from lot no. 41865 may have been sent out with Incorrect Instructions for Use (IFU) labeling. If the MAX1 is used as intended there is no risk to the patient as a result of this issue. The correct instructions for Use for the MAX1 Pen is included with this notification. AtriCure will replace any affected product if requested by the facility. Please review and fill out the attached " Acknowledgement Form" and either fax to AtriCure at (513) 644-4753. If you need to contact customer service, their number is 1-866-349-2342.
- Initiated
- 2013-01-14
- Root cause
- Employee error
- Terminated
- 2013-06-11
- Distribution
- Nationwide Distribution including the states of MD, PA and TX.
- Recall number
- Z-0912-2013
- Recall status
- Terminated
- CDRH record ID
- 116050
- FDA classified
- 2013-03-06
- Recall event number
- 64404